NEW YORK (GenomeWeb) – Cantor Fitzgerald today downgraded PerkinElmer to Neutral from Overweight, but maintained the stock's $60 price target, citing a positive long-term outlook and caution in the near term.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.